Clinical Study
The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation
Table 3
The changes in C3 and C4 parameters of patients.
| Patients | C3 (0.9–1.8 g/L) | C4 (0.1–0.4 g/L) | Before TCV | W4 | W8 | Before TCV | W4 | W8 |
| P1 | 0.73↓ | 0.68↓ | 0.98 | 0.12 | 0.11 | 0.14 | P2 | 0.64↓ | 0.95 | 0.93 | 0.12 | 0.21 | 0.27 | P3 | 0.65↓ | 1.3 | 1.09 | 0.05↓ | 0.25 | 0.17 | P4 | 0.56↓ | 0.98 | 0.89↓ | 0.06↓ | 0.11 | 0.12 | P5 | 1.00 | 0.91 | 1.01 | 0.03↓ | 0.09↓ | 0.13 | P6 | 0.38↓ | 0.80↓ | 0.9 | 0.05↓ | 0.16 | 0.15 | P7 | 1.08 | 1.04 | 1.24 | 0.14 | 0.18 | 0.27 | P8 | 0.85↓ | — | 0.69↓ | 0.19 | — | 0.14 | P9 | 0.64↓ | 0.59↓ | 0.62↓ | 0.07↓ | 0.11 | 0.12 | P10 | 0.62↓ | 0.50↓ | 0.61↓ | 0.09↓ | 0.02↓ | 0.11 | P11 | 1.02 | — | 1.05 | 0.16 | — | 0.19 | P12 | 0.64↓ | 0.89↓ | 1.19 | 0.04↓ | 0.13 | 0.21 | P13 | 0.58↓ | 0.66↓ | 0.91 | 0.07↓ | 0.09↓ | 0.11 | P14 | 1.20 | — | 1.27 | 0.25 | — | 0.32 | P15 | 0.58↓ | 0.84↓ | 0.79 | 0.16 | 0.19 | 0.16 | P16 | 1.43 | — | 1.38 | 0.42↑ | — | 0.48 |
| value | | | | | | |
|
|
“—” means data absence.
|